ARCHIVES

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999

Advisors Approve Lung Screening Trial Testing Spiral CT Vs. X-Ray, For $200M.

November 23, 2001

RFAs Available.

July 4, 2003

In Brief: NBCC Wins Grants To Train Breast Cancer Activists In Language, Concepts Of Science

January 13, 1995

ASCO Recommends Discussing Pharmacological Prevention

July 26, 2013

In Brief: John Young to Leave NCI for ELM; Yates Looking for Chief Of Outpatient Services At RPI

March 18, 1988